Deerfield Management logo

Deerfield Management

Crunchbase
Pitchbook

Deals on record

7

Common Fundraising Type

Series C

Nema Health logo
Nema Health

Virtual Treatment Provider

Deerfield Management logo
Optum Ventures logo
GreyMatter logo
.406 Ventures logo
CVS Health Ventures logo

Nema Health provides virtual treatment for PTSD, offering a comprehensive care program including therapists, peer mentors, case managers, and psychiatrists, with plans to expand nationwide and partner with additional insurance plans.

Series A
$14.5M
01/08/2025
Article
Pleno logo
Pleno

Clinical diagnostics

Medical Excellence Capital logo
Foresite Capital logo
Deerfield Management logo

Pleno, Inc. is a clinical and multi-omics diagnostics company focused on revolutionizing biological target detection with its RAPTOR™ multi-omic instrument platform.

Series B
$25M
12/12/2024
Article
Petfolk logo
Petfolk

Veterinary care

Petfolk is a modern veterinary care company that provides in-person and virtual veterinary services through their pet care centers and mobile app, aiming to reshape the veterinary profession by providing best-in-class service and elevating veterinarians through their Partner Program.

Series C
$36M
10/29/2024
Article
SpectraWAVE logo
SpectraWAVE

Medical imaging

SV Health Investors logo
S3 Ventures logo
NovaVenture logo
Johnson & Johnson Innovation - JJDC logo
Heartwork Capital logo
Deerfield Management logo
Lumira Ventures logo

SpectraWAVE, Inc. develops advanced medical imaging systems to improve coronary stenting procedures and enhance clinical decision-making in the treatment of coronary artery disease.

Series B
$50M
09/11/2024
Article
Bicara Therapeutics logo
Bicara Therapeutics

Biotechnology

TPG logo
Deerfield Management logo
Braidwell logo
Aisling Capital logo
Fairmount logo

Bicara Therapeutics is a clinical-stage biotech company focused on developing BCA101, a novel bifunctional inhibitor targeting EGFR and TGF-β pathways for the treatment of various cancers.

Series C
$165M
12/12/2023
Article
Adela logo
Adela

Blood Testing

RA Capital Management logo
OrbiMed logo
Labcorp logo
F-Prime Capital logo
Deerfield Management logo
Decheng Capital logo

Adela is a healthcare technology company that specializes in blood testing for early cancer detection and minimal residual disease monitoring using a genome-wide methylome enrichment platform.

Equity
$48M
09/26/2023
Article
Actio Biosciences logo
Actio Biosciences

Biotechnology

Canaan logo
DROIA Ventures logo
EcoR1 logo
Euclidean Capital logo
Deerfield Management logo

Actio Biosciences is a biotechnology company that uses its proprietary platform for genetics and precision medicine to develop therapeutics for both rare and common diseases, with a focus on TRPV4 mutations for the treatment of Charcot-Marie-Tooth disease type 2C and other serious bone diseases.

Series A
$55M
09/12/2023
Article